AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 288: G1110-G1117, 2005. First published January 27, 2005; doi:10.1152/ajpgi.00364.2004
0193-1857/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/6/G1110    most recent
00364.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Padol, I. T.
Right arrow Articles by Hunt, R. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Padol, I. T.
Right arrow Articles by Hunt, R. H.

TRANSLATIONAL PHYSIOLOGY

Host-specific differences in the physiology of acid secretion related to prostaglandins may play a role in gastric inflammation and injury

Ireneusz T. Padol and Richard H. Hunt

Intestinal Disease Research Programme, McMaster University, Hamilton, Ontario, Canada

Submitted 12 August 2004 ; accepted in final form 18 January 2005

ABSTRACT

Immune mediators are involved in strain-specific manifestations of Helicobacter pylori infection, and the type of immune response is associated with production of PGE2, which in turn influences gastric acid secretion. Acid secretion plays a pivotal role, not only in the pattern of H. pylori-induced gastritis and its consequences, but also in nonsteroidal anti-inflammatory drug (NSAID)-induced gastropathies. Mice and their transgenic modifications are widely used in Helicobacter and eicosanoid research. Using [14C]aminopyrine accumulation and pylorus ligation, we aimed to study acid secretion in gastric gland preparations from the commonly used strains of BALB/c and C57BL/6 mice. We found that PGE2 does not inhibit acid secretion in gastric glands from C57BL/6 mice, in contrast to the expected antisecretory effect of PGE2 observed in BALB/c mice. In BALB/c mice the effect of histamine and carbachol was reduced by PGE2, whereas in C57BL/6 mice dose-response curves to these secretagogues were not affected. EP3 receptors are not involved in acid secretion in C57BL/6 mice, as confirmed by significantly lower expression of mRNA for the EP3 receptor. These contrary findings are important to the interpretation of the antisecretory role of eicosanoids in BALB/c and C57BL/6 mouse strains and the involvement of prostanoids in the etiology of Helicobacter-induced inflammation and NSAID-induced gastropathies. We propose that the lack of antisecretory effect of PGE2 observed in C57BL/6 mice could reflect the extent of Helicobacter-induced inflammation and status of acid secretion in response to anti-inflammatory drugs.

gastric glands; gastric acid; mouse; prostaglandin E2; BALB/c; C57BL/6; histamine; carbachol; somatostatin; omeprazole; ranitidine; butaprost; sulprostone; misoprostol; EP3 receptor



Address for reprint requests and other correspondence: R. H. Hunt, Div. of Gastroenterology, McMaster Univ., Health Sciences Centre, Rm. 4W8A, 1200 Main St. West, Hamilton, ON, Canada L8N 3Z5 (E-mail: huntr{at}mcmaster.ca)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.